Sort   by:  
 Page size 
UnknownA Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.
Not available
S-EPMC4708614 | biostudies-literature
UnknownEvaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight.
Not available
S-EPMC5445230 | biostudies-literature
UnknownRandomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis.
Not available
S-EPMC6032846 | biostudies-literature
UnknownThe metalloproteinase Papp-aa controls epithelial cell quiescence-proliferation transition.
Not available
S-EPMC7185994 | biostudies-literature
UnknownPregnancy associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2) but not PAPP-A are associated with circulating total IGF-1 in a human adult population.
Not available
S-EPMC10799854 | biostudies-literature
UnknownThe effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2.
Not available
S-EPMC9828059 | biostudies-literature
UnknownA randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.
Not available
S-EPMC3761190 | biostudies-literature
UnknownStructure of the PAPP-ABP5 complex reveals mechanism of substrate recognition.
Not available
S-EPMC9489782 | biostudies-literature
UnknownInhibition of longevity regulator PAPP-A modulates tissue homeostasis via restraint of mesenchymal stromal cells.
Not available
S-EPMC7963332 | biostudies-literature
UnknownLow PAPP-A levels and their association with adverse perinatal outcomes in twin pregnancies.
Not available
S-EPMC12816117 | biostudies-literature
Sort   by:  
 Page size